Dec
2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
Visit us
stand H2.D38

SHIJIAZHUANG LONZEAL PHARMACEUTICALS CO., LTD.

About Us

Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd. was founded on December 30th 2006. Lonzeal’s current core business is research and development, production and sales of anti-AIDS and hepatitis B drugs. We are now one of the most competitive manufacturers of anti-retrovirus (ARV for HIV and HBV) drugs in China, with product registration at international drug authorities including WHOPQ, China, India, Russia, Brazil and South Africa.

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Employees:
    500 - 999
Company types
Pharmaceutical company
Contact info
Event information
CPHI Middle East 2026
  • 14 Dec 2026 - 16 Dec 2026
  • Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
  • Visit us at stand H2.D38

Products Featured at CPHI Middle East 2026

  • Baloxavir Marboxil

    Product Baloxavir Marboxil

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes Baloxavir Marboxil. Product not provided to where patent is still valid
  • Pregabalin

    Product Pregabalin

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes Pregabalin.
  • Emtricitabine

    Product Emtricitabine

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes Emtricitabine.
  • Lamivudine

    Product Lamivudine

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes lamivudine. It belongs to antiviral drugs APIi category. APIplication: anti-viral drug substance. Contact us for more information.
  • Tenofovir Alafenamide Fumarate(TAF)

    Product Tenofovir Alafenamide Fumarate(TAF)

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes TAF.  Product not provided to where patent is still valid